Lifestyle Intervention for Pakistani Women in Oslo
InnvaDiab
Evaluation of a Lifestyle Intervention to Prevent Type 2 Diabetes/Metabolic Syndrome Among Pakistani Immigrants - Focusing on Changes in Diet and Physical Activity
2 other identifiers
interventional
198
1 country
1
Brief Summary
Immigrants from South Asia in Norway have a high prevalence of type 2 diabetes and conditions related to the metabolic syndrome. It has been documented that these conditions may be prevented by changes in lifestyle. No previous intervention studies on immigrants with focus on diet and physical activity have been carried out in Norway. This project concerns a randomized controlled trial with intervention to change diet and physical activity in 200 high risk female Pakistani immigrants living in Oslo. The intervention will be evaluated both in terms of outcome and process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2006
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 19, 2007
CompletedFirst Posted
Study publicly available on registry
January 22, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedResults Posted
Study results publicly available
July 21, 2014
CompletedJuly 21, 2014
April 1, 2014
2.4 years
January 19, 2007
April 11, 2014
June 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The Fasting Plasma Glucose Value, Baseline
baseline
Plasma Glucose 2 h After Oral Glucose Tolerance Test, Baseline
baseline
The Fasting Plasma Glucose, Post-test
post-test
Plasma Glucose, 2-h, Post-test
post-test
Secondary Outcomes (32)
HbA1c, Baseline
baseline
C-peptide, 0-h, Baseline
baseline
C-peptid, 2-h, Baseline
baseline
Insulin, 0-h, Baseline
baseline
Insulin, 2-h, Baseline
baseline
- +27 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALThe intervention group was divided into nine subgroups of ten to twelve women who were offered six educational sessions, each lasting 2 h, during a 7 +- 1-month period. The main focus was on the physiological importance of blood glucose and its regulation by diet and physical activity, and on knowledge about the Pakistani lifestyle in Pakistan and Norway
Control
NO INTERVENTIONOne lesson recieved after post-test
Interventions
The intervention will include a combination of individual counselling group sessions. The intervention groups will be divided into subgroups of 10-12 subjects. Each group will have 10 group sessions on diet/lifestyle in the 6 months the intervention period lasts, and will additionally have the possibility to join a culturally adapted exercise program of low intensity twice a week.
Eligibility Criteria
You may qualify if:
- Risk score developed by Ramachandran et al for Asian Indians:
- BMI, waist circumference, family history of diabetes and sedentary physical activity
You may not qualify if:
- Type 1 diabetes.
- Positive auto antibodies.
- Diagnosis of type 2 diabetes more than 6 months.
- Medication for type 2 diabetes.
- Pregnancy at intervention start.
- Suffering from heart attack or stroke the last 3 months.
- Already participating in organised physical exercise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Oslolead
- European Commissioncollaborator
- The Research Council of Norwaycollaborator
Study Sites (1)
Primary Health Care Health Center
Oslo, Holmlia, Oslo, 1255, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Victoria Telle Hjellset
- Organization
- University of Oslo
Study Officials
- PRINCIPAL INVESTIGATOR
Gerd Holmboe-Ottesen, Dr. Philos.
University of Oslo
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
January 19, 2007
First Posted
January 22, 2007
Study Start
April 1, 2006
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
July 21, 2014
Results First Posted
July 21, 2014
Record last verified: 2014-04